A Message from the President
While we weren’t sure exactly what this year would bring, one thing has been crystal clear — the future of cancer immunotherapy is bright, and it’s being shaped by the next generation of innovators. We’ve welcomed a surge of student members to the
Society for Immunotherapy of Cancer (SITC) this year. In fact, student membership is up 20% compared to this time last year. The momentum is real and I’m so proud that SITC is a growing home for the next generation of the field. It’s not too late
to join the SITC family and take advantage of member benefits this year!
One of the most exciting opportunities now open for early career investigators is
SITC’s Sparkathon program. This impactful initiative unites promising scientists in cancer immunotherapy with established leaders, creating a unique environment for scientific exchange, collaboration and leadership development. The upcoming Sparkathon Class of 2026 will focus on the topic “Next-generation Cellular Therapies, T cell Engagers, and Combinations.” For those dedicated to advancing the field, Sparkathon is an experience that can help shape both your science and your career.
Beyond Sparkathon, SITC offers a rich array of programming to help young investigators thrive. Our Early Career Scientist Committee
curates opportunities each year at our Annual Meeting. This year at the 40
th Anniversary Annual Meeting & Pre-Conference Programs, early career attendees can expect to connect with established experts in networking and mentorship sessions, gain valuable insights into grant writing and career development and lay a strong scientific foundation through the
Primer on Tumor Immunology and Cancer Immunotherapy™. The meeting will also be a time to celebrate achievement, as we recognize deserving early scientists through travel awards and fellowships during special ceremonies.
Watching early career investigators grow into leaders is one of SITC’s greatest privileges and it happens because of dedicated mentors, collaborators and advocates who share their knowledge and open doors. Whether you are just starting out or guiding the next generation, SITC provides programs and connections to support your role in shaping the breakthroughs of tomorrow.
Program Spotlight
SITC 2025 Accepting Late-breaking Abstracts (LBAs) – Clinical Only
SITC has doubled the number of oral abstract presentations for late-breaking clinical abstracts this year! Celebrate 40 years of advancing cancer immunotherapy at SITC 2025 by submitting your LBA by Sept. 15 at 5 p.m. PT. LBAs (clinical only) will be considered for oral presentations in a new plenary session as well as other featured sessions. LBAs must address interventional clinical trials in humans and may include supporting preclinical data.
Submit Abstract
Registration Now Open for 2026 Cancer Immunotherapy Winter School,
Feb. 16–18
Register now and join SITC at Cancer Immunotherapy Winter School! This program offers an in-depth exploration of the core principles of tumor immunology and cancer immunotherapy, along with the latest advances in the field.
In addition to essential IO education, there are ample opportunities to expand your professional network and develop new relationships with faculty – including program organizers Kristin Anderson, PhD – University of Virginia, Chrystal Paulos, PhD – Winship Cancer Institute at Emory University, Ryan J. Sullivan, MD – Harvard Medical School, Massachusetts General Hospital and program advisor Daniel J. Powell Jr., PhD – University of Pennsylvania – and other thought leaders through small group breakout sessions.
Register before the New Year to save up to $250 off regular rates - secure your spot today!
Learn More & Register
SITC Lung Cancer Clinical Practice Guideline Update
SITC’s new Lung Cancer and Mesothelioma Clinical Practice Guideline addendum provides up-to-date guidance in rapidly evolving treatment landscapes driven by several new cancer immunotherapy approvals in NSCLC and SCLC.
Read the Guideline
Additional Programming and Events